Fledip s.r.o.

The medical center is at the forefront of research in Endocrinology, focusing on innovative treatments for Type 2 Diabetes and related metabolic disorders. The center's work is pivotal in developing therapies that address the complex interplay between diabetes and obesity, aiming to improve patient outcomes through advanced pharmacological interventions.

• Type 2 Diabetes Management
• Obesity and Overweight Treatment
• Metabolic Syndrome Research

By exploring novel oral medications like Orforglipron, the center contributes significantly to the understanding and management of diabetes, offering alternatives to traditional insulin therapies.

With a strong emphasis on Cardiovascular Diseases, the center is dedicated to reducing the risk of major adverse cardiovascular events (MACE) in patients with comorbid conditions such as diabetes and obesity. The research conducted here is crucial in identifying non-inferior treatment options that can effectively manage cardiovascular risks.

• Cardiovascular Risk Reduction
• Heart Disease Prevention
• Innovative Cardiovascular Therapies

The center's efforts in cardiovascular research are instrumental in developing comprehensive care strategies that integrate metabolic and cardiovascular health.

Specializing in Chronic Kidney Disease, the center is committed to advancing the understanding of kidney health in the context of metabolic disorders. Research here focuses on the impact of diabetes and obesity on kidney function, aiming to develop therapeutic approaches that mitigate renal complications.

• Kidney Function Preservation
• Diabetes-Related Kidney Disease
• Renal Health in Obesity

Through its pioneering research, the center is enhancing the quality of life for patients with chronic kidney conditions by integrating nephrology with metabolic care.